Cotrimoxazol to prevent malaria in HIV-infected pregnant women in Sub-Saharan Africa

Not Applicable

Completed

• Conditions: Malaria HIV vertical transmission; Infections and Infestations; Plasmodium falciparum malaria

• Registration Number: ISRCTN98835811
• Lead Sponsor: AlterSanté (France)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-09-27
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

1. HIV1
2. Women <28 weeks of pregnancy
3. CD4 >200/mm3
4. Hb >7 g/

Exclusion Criteria

1. Age<15
2. HIV2 or HIV1+2
3. Allergy or ongoing sulfamides treatment

Study & Design

• Study Type: Interventional
• Study Design: Not specified